<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B272710A-AD32-4F95-9608-C01C25225F0B"><gtr:id>B272710A-AD32-4F95-9608-C01C25225F0B</gtr:id><gtr:firstName>Vern</gtr:firstName><gtr:surname>Farewell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EC0313E4-3211-4501-8CEC-2863A4D469B5"><gtr:id>EC0313E4-3211-4501-8CEC-2863A4D469B5</gtr:id><gtr:firstName>Fotios</gtr:firstName><gtr:surname>Siannis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600650"><gtr:id>BD1AC8B8-B881-4F65-8EBA-500B88CBC397</gtr:id><gtr:title>Meta-analysis of time-to-event endpoints with individual patient data</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600650</gtr:grantReference><gtr:abstractText>When a number of clinical trials have been carried out to evaluate the effectiveness of a new medical treatment, it is desirable to combine the evidence from these studies. This will support evaluation of the usefulness of the treatment and its adoption as an accepted form of treatment.In this research, we will develop the means of most effectively combining information from studies with a primary goal of delaying an adverse event such as disease remission or death.</gtr:abstractText><gtr:technicalSummary>Our aim is to investigate the area of individual patient data time-to-event meta-analysis from a methodological point of view. We plan to address problems that are known to exist in the analysis of survival and competing risks data, and have been discussed in the literature. Extensions of this work to the meta-analysis framework present new challenges that need to be addressed. We propose the development of parametric models as an alternative to the widely used proportional hazard models. This will provide additional flexibility in terms of modelling different data structures and will also allow the combination of various data structures in the analysis, with the appropriate choice of distributions. Furthermore, the development of non-parametric methods for analysing time-to-event data will provide useful tools for exploring the nature of the data, with no underlying assumptions about their structure. Novel approaches in meta-analysis of time-to-event individual patients data will give insight in the exploration of heterogeneity amongst the studies under investigation. The parametric approach will provide a useful environment for assessing and testing for heterogeneity. Additionally, the presence of informative censoring can be explored within the competing risks framework, and methodology that allows for the presence of more than one endpoint will be developed, inspired by already existing methodology for the analysis of single studies. The analysis of studies under model misspecification, especially for small treatment effects, is of great interest, as well as the ability to perform comparisons between more than two treatments, using both direct and indirect evidence. Finally, the assessment of our methods through well-designed simulation studies and application to past trials, as well as the software development for the execution of these methods, are integral parts of the proposed research.</gtr:technicalSummary><gtr:fund><gtr:end>2009-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>97249</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>MRC Clinical Trials Unit</gtr:description><gtr:id>E5DDF2AA-3B4C-4F76-A38C-8B060FF20549</gtr:id><gtr:impact>PMID: 20963770
- Detailed study of the impact of categorisation of a continuous explanatory variable when interest centres on interactions involving this variable.</gtr:impact><gtr:partnerContribution>Data providing and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Statistical expertise/ Methodological work</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Department of Mathematics</gtr:department><gtr:description>University of Athens</gtr:description><gtr:id>1DCD0D84-CFB5-4469-B01A-0BB343A9E7B9</gtr:id><gtr:impact>PMID: 20963770; 21204119</gtr:impact><gtr:partnerContribution>Joint research and manuscripts preparation</gtr:partnerContribution><gtr:piContribution>Statistical methods</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C4B20321-7BF9-4DEB-A11C-B7626BEABE49</gtr:id><gtr:impact>Each year BSU participate in Cambridge Science Festival - members of the general public explore and discuss issues of scientific interest and concern, through a series of different events. The event also aims to raise aspirations by encouraging young people to consider a career in science, technology, engineering or mathematics.

BSU take part over two full days - 'Science Saturday' and the 'Cambridge Biomedical Campus' day. The unit presents a stand with 4 - 5 interactive activities that each communicate a basic statistical method or idea, representing one of the four research themes in the unit. Each year a new activity is developed and delivered requiring scientific input from staff across the unit. Over the two days, BSU engage with approximately 500 adults and children who visit the festival.

Raised awareness of the Unit's work in the local schools community
Very good feedback from festival attendants</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/science-festival</gtr:url><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>134580</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council - Career development award in biostatistics</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C60EC91C-1B86-4880-A92B-C5D293DE1F1B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Meta-analysis of percentile ratios for time-to-event endpoints with individual patient data</gtr:description><gtr:id>9BCA29BF-4243-47F2-BB8D-8FF879E22626</gtr:id><gtr:impact>No</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Percentile ratios in meta-analysis</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEFA37D0-2430-4414-AA1D-03FA2C0EE08C"><gtr:id>FEFA37D0-2430-4414-AA1D-03FA2C0EE08C</gtr:id><gtr:title>Clinicians' attitudes towards clinical trials of cancer therapy.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b37a120d236cc7f8b08242cf86cec28d"><gtr:id>b37a120d236cc7f8b08242cf86cec28d</gtr:id><gtr:otherNames>Ford E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E47E7D32-5481-4848-A50E-FA1B8A259BC8"><gtr:id>E47E7D32-5481-4848-A50E-FA1B8A259BC8</gtr:id><gtr:title>Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5569c761d204c6033a9730736dccfe4c"><gtr:id>5569c761d204c6033a9730736dccfe4c</gtr:id><gtr:otherNames>Barker RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28A7D70D-5F95-4896-8911-6341C0A2F4F0"><gtr:id>28A7D70D-5F95-4896-8911-6341C0A2F4F0</gtr:id><gtr:title>Two-stage meta-analysis of survival data from individual participants using percentile ratios.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f68e615d9c2624ac665554735c88462e"><gtr:id>f68e615d9c2624ac665554735c88462e</gtr:id><gtr:otherNames>Barrett JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F47B8967-C656-474F-B40E-8CE77495EE56"><gtr:id>F47B8967-C656-474F-B40E-8CE77495EE56</gtr:id><gtr:title>One-stage parametric meta-analysis of time-to-event outcomes.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8673d4fbac0d38f966b6ad3c6ec647ba"><gtr:id>8673d4fbac0d38f966b6ad3c6ec647ba</gtr:id><gtr:otherNames>Siannis F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8F95488-3A27-49AF-B5D6-CBE33547B933"><gtr:id>A8F95488-3A27-49AF-B5D6-CBE33547B933</gtr:id><gtr:title>The use of variance components for the assessment of outcome measures in rheumatology</gtr:title><gtr:parentPublicationTitle>Journal of Applied Statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6b0470ffecdded69bfaf22f2a8b5039"><gtr:id>f6b0470ffecdded69bfaf22f2a8b5039</gtr:id><gtr:otherNames>Allen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD9E4FF4-B25D-4207-8EB7-3682367C78B9"><gtr:id>BD9E4FF4-B25D-4207-8EB7-3682367C78B9</gtr:id><gtr:title>Axial psoriatic arthritis: update on a longterm prospective study.</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68f5105ec7b9f430a03632c91c328a3d"><gtr:id>68f5105ec7b9f430a03632c91c328a3d</gtr:id><gtr:otherNames>Chandran V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FAA754A-C887-44C0-BCFE-FFD25B5A8491"><gtr:id>6FAA754A-C887-44C0-BCFE-FFD25B5A8491</gtr:id><gtr:title>A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f68e615d9c2624ac665554735c88462e"><gtr:id>f68e615d9c2624ac665554735c88462e</gtr:id><gtr:otherNames>Barrett JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE58DA65-7BF2-46C7-8594-4E81D238171E"><gtr:id>BE58DA65-7BF2-46C7-8594-4E81D238171E</gtr:id><gtr:title>Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4427bd0ed7bc34790b20866189c16d15"><gtr:id>4427bd0ed7bc34790b20866189c16d15</gtr:id><gtr:otherNames>Fallowfield L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600650</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>